vancomycin has been researched along with Body Weight in 110 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (7.27) | 18.7374 |
1990's | 14 (12.73) | 18.2507 |
2000's | 10 (9.09) | 29.6817 |
2010's | 64 (58.18) | 24.3611 |
2020's | 14 (12.73) | 2.80 |
Authors | Studies |
---|---|
Calhoun, JH; Schmitt-Hoffmann, A; Shapiro, S; Thomas, JK; Yin, LY | 1 |
Barabino, P; Castagnola, E; Lorenzi, I; Pistorio, A | 1 |
Abdul-Aziz, MH; Cotta, MO; Farkas, A; Roberts, JA; Wilks, K; Williams, P | 1 |
Flannigan, KL; Greenway, SC; Hirota, SA; Lewis, IA; Mohamud, A; Rahim, H; Taylor, MR | 1 |
Batchelder, N; Frens, J; Lutheran, CF | 1 |
Fujiyoshi, M; Hattori, N; Ishii, I; Suzuki, T; Takatsuka, H; Tatebe, M; Uchida, M; Yamazaki, S | 1 |
Aljutayli, A; Marsot, A; Nekka, F | 1 |
Cao, P; Gao, LL; Li, SC; Nie, YM; Wang, J; Wang, Y; Wu, M; Xu, H; Ye, Q | 1 |
Benegni, S; Corsetti, T; Di Chiara, L; Fragasso, T; Insom, G; Ricci, Z; Vallesi, L | 1 |
Liu, HM; Song, C; Wan, S; Wang, B; Wei, P; Yang, S; Yao, Y; Zhu, GM | 1 |
Chan, M; Heng, ST; Ng, TM; Oon, J; Tam, VH | 1 |
Ferreira, A; Lapa, R; Martins, H; Oliveira, JC; Vale, N | 1 |
Guo, X; Liang, H; Sun, L; Zhang, L | 1 |
Hartinger, JM; Pilková, A | 1 |
Chen, M; Chen, Y; Jing, L; Li, C; Liu, TT; Lu, J; Lv, C; Wei, Y; Zhang, R; Zhou, S | 1 |
Wei, X; Xiao, X; Zhao, M | 1 |
Chen, CY; Cui, YM; Liu, YO; Ma, LY; Sheng, XY; Zhou, Y | 1 |
Du, G; Qian, X; Weng, C; Zhou, H; Zhou, X | 1 |
Gastonguay, MR; Himebauch, AS; Ramsey, EZ; Reedy, MD; Topjian, AA; Zane, NR; Zuppa, AF | 1 |
Hartinger, J; Hronová, K; Šíma, M; Slanař, O | 1 |
Brown, ML; Childress, DT; Gaillard, PR; Hutchison, AM; McAtee, AM | 1 |
Arai, T; Hamano, Y; Ishigami, A; Ishii, T; Kishimoto, Y; Kondo, Y; Lee, J; Masutomi, H; Mori, Y; Shimazaki, Y; Takigawa, M | 1 |
Jang, IJ; Lee, S; Park, KR; Park, WB; Song, SH; Yoon, S; Yu, KS | 1 |
Li, X; Sun, S; Wang, Q; Wu, Y; Zhao, Z | 1 |
Buising, K; Hui, K; Kirkpatrick, CMJ; Kong, DCM; Nalder, M; Nelson, C; Pedagogos, E; Upjohn, L | 1 |
Chin, SJ; Clarke, HD; Moore, GA; Spangehl, MJ; Young, SW; Zhang, M | 1 |
Chaix, A; Chang, MW; Knight, R; Marotz, CA; Panda, S; Saghatelian, A; Xu, ZZ; Zarrinpar, A | 1 |
Crass, RL; Dunn, R; Hong, J; Krop, LC; Pai, MP | 1 |
Hickerson, WL; Hill, DM; Lanfranco, J; Romero Legro, I; Sinclair, SE; Velamuri, SR | 1 |
Bourji, J; Fahs, IM; Hallit, R; Hallit, S; Malaeb, DN; Saad, M; Salameh, P | 1 |
Akcan Arikan, A; Dutta, A; Ivaturi, V; Moffett, BS; Morris, J | 1 |
Cheng, R; Guo, J; He, F; Huang, C; Li, H; Li, M; Pu, F; Shi, L; Wan, C; Yang, Y | 1 |
Fukui, H; Miwa, H; Oshima, T; Ran, Y; Tomita, T; Watari, J; Xu, X | 1 |
Černá, O; Pokorná, P; Šíma, M; Slanař, O | 1 |
Allegaert, K; Černá, O; Pokorná, P; Šíma, M; Slanař, O; Tibboel, D | 1 |
Allegaert, K; Biran, V; Capparelli, EV; Jacqz-Aigrain, E; Leroux, S; Lo, YL; Lutsar, I; Marques, R; Meibohm, B; Nakamura, H; Peris, JE; Saito, J; Sharland, M; Simon, N; Thomson, AH; van den Anker, JN; Zhao, W | 1 |
Avedissian, SN; Chang, J; Griffin, B; Gulati, A; Hlukhenka, K; Joshi, MD; Lamar, PC; Pais, GM; Prozialeck, WC; Scheetz, MH; Zhang, Z | 1 |
Burgess, DS; Hall, RG; Rutter, WC | 1 |
Alvarez, CA; Bedimo, RJ; Bell, T; Brouse, SD; Forcade, NA; Frei, CR; Giuliano, CA; Haase, KK; Hall, RG; Hazlewood, KA | 1 |
Grovola, MR; Jasani, NB; Levine, BJ; Rosini, JM | 1 |
Arpino, PA; Golenia, BS; Levine, AR; Moawad, IM; Yeh, DD | 1 |
Frymoyer, A; Guglielmo, BJ; Hersh, AL | 1 |
Heble, DE; Hunstad, DA; McPherson, C; Nelson, MP | 1 |
Ampofo, K; Lubsch, L; Noyes, BE; Olson, J; Sherwin, CM; Spigarelli, MG; Stockmann, C; Young, DC; Zobell, JT | 1 |
Banerjee, R; Graner, KK; Madigan, T; Sieve, RM | 1 |
Healy, D; Kagan, R; Neely, A; Sherwin, CM; Spigarelli, MG; Stockmann, C; Wead, S | 1 |
Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
Camaione, L; Elliott, K; Lomaestro, B; Mitchell-Van Steele, A; Pai, MP | 1 |
Frankel, KC; Jasani, NB; Levine, BJ; Papas, MA; Rosini, JM | 1 |
Cassat, JE; Di Pentima, MC; Gillon, JE | 1 |
Barber, GR; Cleveland, JC; Fish, DN; Hafermann, MJ; Kiser, TH; Lyda, C; Wempe, MF | 1 |
Allegaert, K; Brussee, JM; Danhof, M; De Cock, RF; de Hoog, M; Knibbe, CA; Mulla, H; Sherwin, CM; van den Anker, JN | 1 |
Drover, DR; El-Komy, MH; Frymoyer, A; Gaskari, S; Hersh, AL; Su, F; Van Meurs, K | 1 |
Alvarez, CA; Bedimo, RJ; Bell, T; Blaszczyk, AT; Brouse, SD; Forcade, NA; Frei, CR; Giuliano, CA; Hall, RG; Mortensen, EM; Thompson, KA | 1 |
Frenck, RW; Hahn, A; Vinks, AA; Zou, Y | 1 |
Adane, ED; Herald, M; Koura, F | 1 |
Beck, GL; Matson, KL; Shaffer, CL; Simonsen, KA | 1 |
Chen, BY; Dong, MH; Wang, JW; Wen, AD; Wu, Y; Yu, M | 1 |
Baillon-Plot, N; Charbonneau, C; Corman, S; Eckmann, C; Haider, S; Lawson, W; Li, J; Macahilig, C; Nathwani, D; Solem, C; Stephens, J | 1 |
Molina, N; Nicolau, DP; Pourmand, D; Schwarzkopf, R; Sharareh, B; Sutherland, C | 1 |
Arnold, R; Comer, D; Davis, JJ; Levine, BJ; Muenzer, J; Papas, MA; Rosini, JM | 1 |
Bourguignon, L; Cazaubon, Y; Debeurme, G; Ducher, M; Goutelle, S; Loue, C | 1 |
Maxson, R; Pate, J; Starr, J | 1 |
Ewald, U; Friberg, LE; Honoré, PH; Nielsen, EI; Sandström, M | 1 |
Aksoy, NH; Baykal, A; Celik-Ozenci, C; Dalaklioglu, S; Gungor, NE; Tasatargil, A; Tekcan, M | 1 |
Anderson, PO; Capparelli, EV; Cornejo-Bravo, JM; Dominguez, AR; Lane, JR; Sánchez, JL | 1 |
Edwards, MS; Kim, S; Moffett, BS | 1 |
Boro, MS; Leong, JV; Winter, M | 1 |
Hewton, C; Jones, TE; Vasileff, H | 1 |
De Bacquer, D; De Vriese, AS; Vandecasteele, SJ | 1 |
Brown, M; Cuhaci, B; Gracely, EJ; Polisetty, R; Schlecht, HP | 1 |
Erstad, BL; Matthias, KR; Nix, DE | 1 |
Kirkpatrick, CM; Li, J; Lipman, J; Roberts, JA; Udy, AA | 1 |
Boulamery, A; Bruguerolle, B; Marsot, A; Simon, N | 1 |
Hakamata, Y; Kim, MR; Le, M; Maki, N; Matsubara, S; Ohkuchi, A; Sakamoto, T; Tashiro, Y | 1 |
Frazee, EN; Kashani, KB; Kuper, PJ; Larson, SL; Leung, N; Osmon, DR; Schramm, GE | 1 |
Bracken, TC; Figler, RA; Guerrant, RL; Kolling, G; Li, Y; Linden, J; Rieger, J; Stevenson, RW; Warren, CA | 1 |
Fuller, BM; McCammon, C; Mohr, N; Mueller, K; Skrupky, L | 1 |
Chung, JY; Jin, SJ; Song, YG; Yoon, JH | 1 |
Gefen, A; Hadad, S; Kassis, I; Krivoy, N; Mashiach, T; Nassar, L; Shachor-Meyouhas, Y | 1 |
Kimura, T; Kubo, H; Matsuura, N; Shimada, S; Sunakawa, K; Yago, K | 1 |
Brandt, B; Gosheger, G; Joist, A; Joosten, U; Liljenqvist, U; von Eiff, C | 1 |
Brøsen, K; Frimodt-Møller, N; Gahrn-Hansen, B; Madsen, H | 1 |
Ariano, RE; Fine, A; Rexrode, S; Sitar, DS; Zelenitsky, SA | 1 |
Boro, MS; Lee, E; Winter, ME | 1 |
Bateman, CV; Gillespie, DE; Murphy, JE | 1 |
Kimura, T; Kokubun, H; Yago, K | 1 |
Liston, TE | 1 |
Aronoff, GR; Dinwiddie, CB; Fineberg, NS; Glant, MD; Luft, FC; Sloan, RS | 1 |
Gross, DJ | 1 |
Ducharme, MP; Edwards, DJ; Slaughter, RL | 1 |
Phleps, SJ; Wandstrat, TL | 1 |
Gilliland, SS; Guay, DR; Rodvold, KA; Rotschafer, JC; Vance-Bryan, K | 1 |
Frankewitsch, T; Keller, F; Simon, S; Zellner, D | 1 |
Furlanut, M; Wu, G | 1 |
Gubbins, PO; Hickerson, SL; Penzak, SR; Rodvold, KA | 1 |
Hori, R; Iga, T; Oguma, T; Okumura, K; Yano, Y; Yasuhara, M; Zenda, H | 1 |
Bauer, LA; Black, DJ; Lill, JS | 1 |
Almeida, AM; Bispo, MA; Costa, IM; Falcão, AC; Falcão, F; Palminha, JM; Reis, E; Silva, R | 1 |
DiPersio, D; Haas, DW; Klekamp, JW | 1 |
Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T | 1 |
Andoh, A; Araki, Y; Bamba, T; Fujiyama, Y; Fukuda, M; Fukuoka, M; Kanauchi, O; Matsumoto, Y; Mitsuyama, K; Sata, M; Takagi, K; Toyonaga, A | 1 |
Alsar, MJ; Sacristán, JA; Soto, J | 1 |
Dupuis, L; Koren, G; Levy, M; Read, SE | 1 |
Adams, K; Mader, JT | 1 |
Folli, HL; Gabriel, MH; Kildoo, CW; Lin, LM; Modanlou, HD | 1 |
Brown, DL; Mauro, LS | 1 |
Crane, LR; Duman, K; Hatfield, SM; Karanes, C; Kiel, RJ | 1 |
Bistrian, BR; Blackburn, GL; Tayek, JA | 1 |
Gilbert, DN; Houghton, DC; Kohlhepp, SJ; Kohnen, PW; Wood, CA | 1 |
8 review(s) available for vancomycin and Body Weight
Article | Year |
---|---|
An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults.
Topics: Adult; Anti-Bacterial Agents; Body Weight; Creatinine; Humans; Models, Biological; Vancomycin | 2020 |
Obesity-associated changes in drug pharmacokinetics.
Topics: Anti-Bacterial Agents; Body Weight; Humans; Obesity; Pharmaceutical Preparations; Vancomycin | 2020 |
Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.
Topics: Area Under Curve; Body Weight; Drug Monitoring; Humans; Microbial Sensitivity Tests; Renal Dialysis; Vancomycin | 2018 |
Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Gestational Age; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Monte Carlo Method; Randomized Controlled Trials as Topic; Research Design; Vancomycin | 2019 |
Vancomycin: a review of population pharmacokinetic analyses.
Topics: Age Factors; Anti-Bacterial Agents; Body Weight; Humans; Metabolic Clearance Rate; Models, Biological; Vancomycin | 2012 |
[Antibiotics and overweight].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Body Weight; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Obesity; Penicillins; Quinolones; Vancomycin | 2005 |
[Appropriate usage of antibiotics by therapeutic drug monitoring].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Dibekacin; Drug Administration Schedule; Drug Monitoring; Extracellular Fluid; Humans; Infant, Newborn; Kidney; Patient Care Team; Renal Dialysis; Renal Insufficiency; Teicoplanin; Vancomycin | 2007 |
Vancomycin dosing in neonatal patients: the controversy continues.
Topics: Aging; Bacterial Infections; Body Weight; Drug Administration Schedule; Humans; Infant, Newborn; Infant, Premature; Kidney; Vancomycin | 1994 |
7 trial(s) available for vancomycin and Body Weight
Article | Year |
---|---|
Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Craniotomy; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Vancomycin; Young Adult | 2018 |
The AAHKS Clinical Research Award: Intraosseous Regional Prophylaxis Provides Higher Tissue Concentrations in High BMI Patients in Total Knee Arthroplasty: A Randomized Trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Awards and Prizes; Body Mass Index; Body Weight; Cefazolin; Female; History, 21st Century; Humans; Male; Middle Aged; Obesity; Obesity, Morbid; Orthopedics; Osteoarthritis, Knee; Prospective Studies; Prosthesis-Related Infections; Subcutaneous Fat; Vancomycin | 2018 |
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aortic Valve; Body Weight; Cardiopulmonary Bypass; Colorado; Coronary Artery Bypass; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Heart Valve Prosthesis Implantation; Humans; Infusions, Parenteral; Male; Middle Aged; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2014 |
Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study.
Topics: Age Factors; Biomarkers; Body Weight; Cefuroxime; Creatinine; Cystatin C; Drug Interactions; Female; Gentamicins; Gestational Age; Humans; Indomethacin; Infant; Infant, Newborn; Infant, Premature; Male; Nonlinear Dynamics; Vancomycin | 2009 |
Population pharmacokinetics of arbekacin, vancomycin, and panipenem in neonates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Creatinine; Dibekacin; Female; Gestational Age; Glomerular Filtration Rate; Humans; Infant, Newborn; Male; Models, Biological; Population; Thienamycins; Vancomycin | 2004 |
No influence of large volume blood loss on serum vancomycin concentrations during orthopedic procedures.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Blood Loss, Surgical; Blood Volume; Body Weight; Drug Monitoring; Fluid Therapy; Humans; Microbial Sensitivity Tests; Middle Aged; Orthopedic Procedures; Prospective Studies; Resuscitation; Time Factors; Vancomycin | 1999 |
95 other study(ies) available for vancomycin and Body Weight
Article | Year |
---|---|
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus.
Topics: Animals; Body Weight; Cephalosporins; Disease Models, Animal; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia | 2008 |
Antibiotic defined daily dose in pediatrics. A single center study to proof the principle that a specific pediatric definition could be not needed.
Topics: Anti-Bacterial Agents; Body Weight; Child; Hospitalization; Humans; Meropenem; Vancomycin | 2023 |
In silico Evaluation of a Vancomycin Dosing Guideline Among Adults with Serious Infections.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Body Weight; Humans; Microbial Sensitivity Tests; Vancomycin | 2023 |
Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity.
Topics: Animals; Bacteria; Bacterial Proteins; Body Weight; Colitis; Disease Models, Animal; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Glucuronidase; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mycophenolic Acid; Up-Regulation; Vancomycin | 2019 |
Evaluation of a modified vancomycin nomogram for obese adults.
Topics: Anti-Bacterial Agents; Body Weight; Creatinine; Female; Humans; Male; Middle Aged; Nomograms; Obesity; Retrospective Studies; Vancomycin | 2020 |
Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Body Weight; Continuous Renal Replacement Therapy; Dose-Response Relationship, Drug; Female; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Organ Dysfunction Scores; Polymethyl Methacrylate; Reproducibility of Results; Retrospective Studies; Vancomycin; Young Adult | 2020 |
Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Computer Simulation; Drug Administration Schedule; Drug Elimination Routes; Febrile Neutropenia; Female; Glomerular Filtration Rate; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Treatment Outcome; Vancomycin | 2020 |
Vancomycin prophylaxis in paediatric patients following cardiac surgery: a retrospective evaluation of trough levels and associated variables.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Weight; Cardiac Surgical Procedures; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Vancomycin | 2020 |
Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo.
Topics: Aldehyde Oxidoreductases; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Biofilms; Body Weight; Cell Survival; Disease Models, Animal; Gene Expression Regulation, Bacterial; Houseflies; Humans; Larva; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; RNA, Bacterial; Sigma Factor; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2021 |
Validation of Vancomycin Dosing Guidance During Transition of Care.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Weight; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Middle Aged; Sociodemographic Factors; Transitional Care; Vancomycin | 2021 |
Topics: Age Factors; Anti-Bacterial Agents; Body Weight; Computer Simulation; Dose-Response Relationship, Drug; Drug Elimination Routes; Drug Monitoring; Duration of Therapy; Female; Humans; Infections; Kidney Function Tests; Male; Middle Aged; Vancomycin | 2021 |
Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants.
Topics: Bacteremia; Body Weight; Catheter-Related Infections; Catheterization, Central Venous; Catheters; Humans; Infant; Infant, Newborn; Infant, Premature; Retrospective Studies; Vancomycin | 2021 |
Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Bayes Theorem; Body Weight; Child; Child, Preschool; China; Computer Simulation; Female; Humans; Kidney Function Tests; Male; Models, Biological; Reproducibility of Results; Vancomycin | 2021 |
Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Body Weight; Chemotherapy-Induced Febrile Neutropenia; Creatinine; Daptomycin; Dose-Response Relationship, Drug; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Staphylococcal Infections; Teicoplanin; Vancomycin | 2021 |
Population pharmacokinetics of vancomycin in Chinese infants
.
Topics: Administration, Intravenous; Age Factors; Anti-Bacterial Agents; Asian People; Body Weight; China; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Linear Models; Male; Metabolic Clearance Rate; Models, Biological; Retrospective Studies; Vancomycin | 2017 |
Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; China; Critical Care; Drug Monitoring; Female; Glomerular Filtration Rate; Hospitalization; Hospitals; Humans; Incidence; Intensive Care Units; Kidney; Male; Middle Aged; Retrospective Studies; Safety; Vancomycin | 2017 |
A Population Pharmacokinetic Analysis to Study the Effect of Therapeutic Hypothermia on Vancomycin Disposition in Children Resuscitated From Cardiac Arrest.
Topics: Adolescent; Anti-Bacterial Agents; Body Temperature; Body Weight; Child; Child, Preschool; Combined Modality Therapy; Critical Care; Female; Heart Arrest; Humans; Hypothermia, Induced; Infant; Kidney; Male; Metabolic Clearance Rate; Models, Biological; Resuscitation; Retrospective Studies; Vancomycin | 2017 |
A simulation of loading doses for vancomycin continuous infusion regimens in intensive care.
Topics: Aged; Body Weight; Computer Simulation; Critical Care; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Obesity; Retrospective Studies; Vancomycin | 2017 |
Allometric versus consensus guideline dosing in achieving target vancomycin trough concentrations.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Size; Body Weight; Consensus; Dose-Response Relationship, Drug; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Obesity; Practice Guidelines as Topic; Retrospective Studies; Vancomycin | 2017 |
Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Kidney; Liver; Male; Mice; Mice, Inbred C57BL; Organ Size; Vancomycin | 2017 |
Assessment of Appropriateness of an Initial Dosing Regimen of Vancomycin and Development of a New Dosing Nomogram.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Body Weight; Creatinine; Decision Support Techniques; Drug Administration Schedule; Drug Dosage Calculations; Drug Monitoring; Female; Hospitals, University; Humans; Male; Middle Aged; Models, Biological; Nomograms; Retrospective Studies; Seoul; Vancomycin; Young Adult | 2018 |
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Blood Glucose; Body Composition; Body Weight; Cecum; Colon; Fatty Acids, Volatile; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neomycin; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Dosing vancomycin in the super obese: less is more.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Body Weight; Creatinine; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Nomograms; Obesity; Staphylococcal Infections; Vancomycin; Young Adult | 2018 |
Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Topics: Acute Kidney Injury; Adult; Age Factors; Aged; Algorithms; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Cohort Studies; Continuous Renal Replacement Therapy; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Retrospective Studies; Sex Factors; Vancomycin; Young Adult | 2019 |
Assessment of vancomycin utilization among Lebanese hospitals.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Weight; Creatinine; Drug Monitoring; Drug Utilization Review; Female; Guideline Adherence; Hospitals; Humans; Lebanon; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Vancomycin; Young Adult | 2019 |
Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Female; Humans; Male; Microbial Sensitivity Tests; Vancomycin | 2019 |
Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood.
Topics: Aging; Animals; Animals, Newborn; Bifidobacterium bifidum; Body Weight; Ceftriaxone; Cell Differentiation; Colony Count, Microbial; Cytokines; Enterocytes; Fatty Acids; Feces; Gastrointestinal Microbiome; Immunity; Immunoglobulin E; Intestines; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Ovalbumin; Phylogeny; Spleen; Vancomycin | 2019 |
Alteration of GLP-1/GPR43 expression and gastrointestinal motility in dysbiotic mice treated with vancomycin.
Topics: Animals; Body Weight; Dysbiosis; Female; Gastrointestinal Microbiome; Gastrointestinal Motility; Gastrointestinal Tract; Glucagon-Like Peptide 1; Mice; Receptors, G-Protein-Coupled; Vancomycin | 2019 |
Nomogram based on actual body weight for estimation of vancomycin maintenance dose in infants.
Topics: Anti-Bacterial Agents; Body Weight; Drug Monitoring; Female; Humans; Infant; Male; Nomograms; Regression Analysis; Sepsis; Staphylococcus; Vancomycin | 2019 |
Actual body weight-based vancomycin dosing in neonates.
Topics: Anti-Bacterial Agents; Body Weight; Drug Monitoring; Female; Humans; Infant, Newborn; Male; Nomograms; Sepsis; Vancomycin | 2019 |
Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.
Topics: Animals; Animals, Newborn; Body Weight; Female; Fetus; Kidney; Kidney Diseases; Placenta; Pregnancy; Prenatal Care; Rats; Rats, Sprague-Dawley; Vancomycin | 2019 |
Impact of total body weight on rate of acute kidney injury in patients treated with piperacillin-tazobactam and vancomycin.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Drug Therapy, Combination; Female; Humans; Kentucky; Male; Middle Aged; Obesity; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2019 |
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Body Weight; Female; Hospitals; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Staphylococcal Infections; Vancomycin | 2013 |
Prescribing habits of vancomycin in the Emergency Department: are we dosing appropriately?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Hospitals, Community; Hospitals, Teaching; Humans; Male; Medication Errors; Middle Aged; Retrospective Studies; Vancomycin; Young Adult | 2013 |
Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patients.
Topics: Anti-Bacterial Agents; Body Weight; Critical Illness; Female; Humans; Intensive Care Units; Male; Middle Aged; Nomograms; Prospective Studies; Retrospective Studies; Vancomycin | 2013 |
Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Vancomycin | 2013 |
Vancomycin trough concentrations in overweight or obese pediatric patients.
Topics: Adolescent; Algorithms; Anti-Bacterial Agents; Body Weight; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Monitoring; Female; Hospitals, Pediatric; Humans; Male; Obesity; Overweight; Retrospective Studies; Vancomycin | 2013 |
Population pharmacokinetics of intermittent vancomycin in children with cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Models, Biological; Nonlinear Dynamics; Staphylococcal Infections; Tissue Distribution; Vancomycin | 2013 |
The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Retrospective Studies; Vancomycin | 2013 |
Amikacin population pharmacokinetics among paediatric burn patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Body Surface Area; Body Weight; Burns; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Multivariate Analysis; Regression Analysis; Sepsis; Vancomycin | 2014 |
Vancomycin dosing in children and young adults: back to the drawing board.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Body Height; Body Surface Area; Body Weight; Child; Child, Preschool; Drug Dosage Calculations; Female; Humans; Infant; Linear Models; Male; Models, Biological; Retrospective Studies; Tissue Distribution; Vancomycin; Young Adult | 2013 |
Computerized provider order entry improves compliance of vancomycin dosing guidelines in the emergency department.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Emergency Medicine; Emergency Service, Hospital; Female; Guideline Adherence; Humans; Male; Medical Order Entry Systems; Medication Errors; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Vancomycin | 2013 |
Validation of two vancomycin nomograms in patients 10 years of age and older.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Weight; Child; Creatine; Female; Guidelines as Topic; Humans; Male; Reproducibility of Results; Vancomycin; Young Adult | 2014 |
Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
Topics: Adolescent; Adult; Aging; Body Weight; Child; Child, Preschool; Creatinine; Gentamicins; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Metabolic Clearance Rate; Models, Biological; Tobramycin; Vancomycin | 2014 |
Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
Topics: Anti-Bacterial Agents; Area Under Curve; Body Weight; Creatinine; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2014 |
Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Body Weight; Cohort Studies; Dose-Response Relationship, Drug; Female; Hospital Mortality; Humans; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Multivariate Analysis; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2014 |
Validation of a pediatric population pharmacokinetic model for vancomycin.
Topics: Anti-Bacterial Agents; Bayes Theorem; Body Weight; Child; Child, Preschool; Creatinine; Female; Humans; Male; Models, Biological; Vancomycin | 2015 |
Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Body Weight; Dose-Response Relationship, Drug; Female; Hospitals, Teaching; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Obesity, Morbid; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Vancomycin | 2015 |
Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.
Topics: Adolescent; Anti-Bacterial Agents; Body Weight; Child; Child, Preschool; Empirical Research; Female; Humans; Kidney Diseases; Male; Retrospective Studies; Vancomycin | 2015 |
Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China.
Topics: Adult; Aged; Anti-Bacterial Agents; Body Weight; China; Female; Humans; Incidence; Kidney; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Vancomycin | 2015 |
Weight-based antibiotic dosing in a real-world European study of complicated skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Daptomycin; Diabetes Complications; Europe; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Peripheral Vascular Diseases; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Teicoplanin; Vancomycin; Young Adult | 2015 |
Effect of Body Weight on Cefazolin and Vancomycin Trabecular Bone Concentrations in Patients Undergoing Total Joint Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty; Body Weight; Bone and Bones; Cefazolin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Prospective Studies; Surgical Wound Infection; Vancomycin | 2016 |
High Single-dose Vancomycin Loading Is Not Associated With Increased Nephrotoxicity in Emergency Department Sepsis Patients.
Topics: Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Emergency Service, Hospital; Humans; Incidence; Kidney Diseases; Patient Admission; Retrospective Studies; Sepsis; Vancomycin | 2016 |
Pharmacokinetics of Vancomycin in Elderly Patients Aged over 80 Years.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Female; Humans; Male; Staphylococcus aureus; Vancomycin | 2016 |
Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
Topics: Aged; Anti-Bacterial Agents; Body Weight; Drug Monitoring; Female; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vancomycin | 2016 |
Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Biomarkers; Blood Urea Nitrogen; Body Weight; Creatine; Isoquinolines; Kidney; Kidney Diseases; Male; Organ Size; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolines; Rats; Rats, Wistar; Vancomycin | 2010 |
Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bias; Body Weight; Female; Humans; Male; Middle Aged; Models, Biological; Nonlinear Dynamics; Retrospective Studies; Tissue Distribution; Vancomycin | 2010 |
Vancomycin dosing in obese pediatric patients.
Topics: Anti-Bacterial Agents; Body Weight; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Male; Obesity; Overweight; Retrospective Studies; Vancomycin | 2011 |
Determining vancomycin clearance in an overweight and obese population.
Topics: Aged; Body Weight; Female; Hospitals, Veterans; Humans; Male; Metabolic Clearance Rate; Middle Aged; Obesity; Overweight; Retrospective Studies; Vancomycin; Veterans | 2011 |
Should monitoring of vancomycin be delayed? A case of likely nephrotoxicity occasioned by morbid obesity and minimal monitoring.
Topics: Anti-Bacterial Agents; Body Weight; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Kidney Diseases; Obesity, Morbid; Vancomycin | 2012 |
Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Dialysis; Time Factors; Vancomycin | 2011 |
Weight-based loading of vancomycin in patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Models, Statistical; Plasma; Renal Dialysis; Vancomycin | 2011 |
Vancomycin clearance in overweight and obese patients.
Topics: Body Weight; Female; Hospitals, Veterans; Humans; Male; Overweight; Vancomycin; Veterans | 2011 |
Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Body Weight; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Middle Aged; Patient Education as Topic; Vancomycin | 2012 |
Initial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adults.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Body Mass Index; Body Weight; Creatinine; Drug Dosage Calculations; Female; Humans; Linear Models; Male; Metabolic Clearance Rate; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Tertiary Care Centers; Vancomycin; Young Adult | 2012 |
Effect of continuous venovenous hemofiltration dose on achievement of adequate vancomycin trough concentrations.
Topics: Aged; Anti-Bacterial Agents; Body Weight; Data Interpretation, Statistical; Endpoint Determination; Female; Hemofiltration; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2012 |
Adenosine A2A receptor activation reduces recurrence and mortality from Clostridium difficile infection in mice following vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Clostridioides difficile; Clostridium Infections; Diarrhea; Disease Models, Animal; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Secondary Prevention; Survival Analysis; Vancomycin | 2012 |
Emergency Department vancomycin use: dosing practices and associated outcomes.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Drug Utilization; Emergency Service, Hospital; Female; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Medication Errors; Middle Aged; Retrospective Studies; Vancomycin | 2013 |
Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biomarkers; Body Weight; Creatinine; Cystatin C; Demography; Female; Humans; Male; Middle Aged; Models, Statistical; Sex Factors; Software; Vancomycin; Young Adult | 2013 |
Prospective evaluation of the dosing regimen of vancomycin in children of different weight categories.
Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Prospective Studies; Vancomycin | 2012 |
Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis.
Topics: Animals; Biological Availability; Body Weight; Bone Cements; C-Reactive Protein; Chronic Disease; Disease Models, Animal; Drug Carriers; Durapatite; Leukocyte Count; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
Topics: Adult; Aged; Bacterial Infections; Biological Availability; Body Weight; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Models, Theoretical; Polymers; Renal Dialysis; Sulfones; Vancomycin | 2005 |
Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Bacterial Agents; Body Weight; Creatinine; Female; Hospitals, Veterans; Humans; Male; Middle Aged; Retrospective Studies; United States; Vancomycin | 2006 |
Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters.
Topics: Anti-Bacterial Agents; Body Weight; Creatinine; Drug Monitoring; Female; Hospitals, Teaching; Humans; Male; Middle Aged; South Carolina; Vancomycin | 2006 |
Clostridium difficile toxin associated with chronic diarrhea and failure to gain weight.
Topics: Body Weight; Chronic Disease; Clostridium Infections; Diarrhea, Infantile; Humans; Infant; Male; Vancomycin | 1983 |
Effects of vancomycin on renal function in rats.
Topics: Animals; Body Weight; Creatinine; Kidney; Male; Osmolar Concentration; Proteinuria; Rats; Rats, Inbred Strains; Time Factors; Vancomycin | 1981 |
Vancomycin.
Topics: Body Weight; Drug Administration Schedule; Humans; Kidney; Vancomycin | 1995 |
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight.
Topics: Adult; Aged; Aging; Body Weight; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Sex Factors; Vancomycin | 1994 |
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Body Weight; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obesity; Retrospective Studies; Vancomycin | 1993 |
Statistical analysis of heterogeneous pharmacokinetic data from the literature.
Topics: Age Factors; Algorithms; Body Height; Body Weight; Data Interpretation, Statistical; Female; Half-Life; Humans; Male; Pharmacokinetics; Vancomycin | 1996 |
Predictions of serum vancomycin concentrations by means of six different equations for calculation of creatinine clearance.
Topics: Analysis of Variance; Anti-Bacterial Agents; Body Weight; Creatinine; Humans; Models, Biological; Predictive Value of Tests; Vancomycin | 1997 |
Therapeutic drug monitoring of vancomycin in a morbidly obese patient.
Topics: Anti-Bacterial Agents; Body Weight; Drug Monitoring; Humans; Male; Middle Aged; Obesity, Morbid; Retrospective Studies; Vancomycin | 1998 |
Population pharmacokinetics of vancomycin in Japanese pediatric patients.
Topics: Adolescent; Age Factors; Body Weight; Child; Child, Preschool; Female; Guidelines as Topic; Humans; Infant, Newborn; Japan; Male; Models, Biological; Regression Analysis; Vancomycin | 1998 |
Vancomycin dosing in morbidly obese patients.
Topics: Adult; Body Weight; Female; Half-Life; Humans; Injections, Intravenous; Male; Obesity, Morbid; Vancomycin | 1998 |
The kinetic profile of vancomycin in neonates.
Topics: Body Weight; Critical Care; Drug Interactions; Female; Gram-Positive Bacterial Infections; Guidelines as Topic; Humans; Indomethacin; Infant; Infant, Newborn; Injections, Intravenous; Male; Metabolic Clearance Rate; Regression Analysis; Retrospective Studies; Tissue Distribution; Vancomycin | 1998 |
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain | 1999 |
Prebiotic treatment of experimental colitis with germinated barley foodstuff: a comparison with probiotic or antibiotic treatment.
Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Weight; Colitis; Diet; Disease Models, Animal; Hordeum; Male; Metronidazole; Phytotherapy; Plant Preparations; Probiotics; Rats; Rats, Sprague-Dawley; Vancomycin | 2002 |
[Initial dosage of vancomycin in neutropenic hematologic patients].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Body Weight; Bone Marrow Transplantation; Creatinine; Female; Hematologic Diseases; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neutropenia; Vancomycin | 1992 |
Vancomycin-induced red man syndrome.
Topics: Body Weight; Child; Child, Preschool; Creatinine; Erythema; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Retrospective Studies; Urea; Vancomycin | 1990 |
Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Bone and Bones; Daptomycin; Female; Methicillin; Osteomyelitis; Penicillin Resistance; Peptides; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Vancomycin pharmacokinetics in infants: relationship to postconceptional age and serum creatinine.
Topics: Body Weight; Creatinine; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Male; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1989 |
Vancomycin dosing chart for use in patients with renal impairment.
Topics: Body Weight; Glomerular Filtration Rate; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Vancomycin | 1988 |
Miconazole-induced alteration in tobramycin pharmacokinetics.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Cholesterol; Drug Interactions; Female; Humans; Kinetics; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Time Factors; Tobramycin; Triglycerides; Vancomycin | 1986 |
The effects of acute clostridium difficile diarrhea on fecal nitrogen content in adult hospitalized patients.
Topics: Adult; Aged; Body Weight; Clostridium Infections; Diarrhea; Energy Intake; Feces; Female; Humans; Male; Middle Aged; Nitrogen; Nutritional Status; Serum Albumin; Vancomycin | 1987 |
Vancomycin enhancement of experimental tobramycin nephrotoxicity.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Drug Synergism; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred F344; Tobramycin; Vancomycin | 1986 |